Cargando…

Opening the box of PANTHORA in Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Korte, Martin, Köster, Reinhard W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527231/ https://www.ncbi.nlm.nih.gov/pubmed/36184585 http://dx.doi.org/10.1038/s41392-022-01204-7

Ejemplares similares

Tainted air: The link between pollution and Alzheimer's disease
por: Walton, Emma Louise
Publicado: (2018)

For better or worse: Immune system involvement in Alzheimer's Disease
por: Walton, Emma L.
Publicado: (2018)

Plasma pTau181 as a biomarker for Alzheimer's disease
por: Meng, Jie, et al.
Publicado: (2020)

Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer's disease?
por: Bass, Britanny, et al.
Publicado: (2015)

The age factor in Alzheimer’s disease
por: Guerreiro, Rita, et al.
Publicado: (2015)

Brain insulin resistance in Alzheimer’s disease
Publicado: (2012)

Alzheimer’s disease: targeting the peripheral circulation
por: Liu, Zhi-Hao, et al.
Publicado: (2023)

Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer’s: treatment perspectives for Alzheimer’s
por: Haag, Natja, et al.
Publicado: (2021)

Highlight: New Solutions and Open Questions in Computational Evolutionary Biology
por: McGrath, Casey
Publicado: (2019)

MicroRNAs circulate around Alzheimer's disease
por: Smith-Vikos, Thalyana, et al.
Publicado: (2013)

Human herpesvirus 4 and adaptive immunity in Alzheimer’s disease
por: Kang, Jian-Sheng, et al.
Publicado: (2020)

Highlight: Tiny Bacterial Genome Opens a Huge Mystery: AT Mutational Bias in Hodgkinia
por: Venton, Danielle
Publicado: (2012)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
por: Zhao, Yingjun, et al.
Publicado: (2022)

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
por: Zhang, Yun, et al.
Publicado: (2020)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Four key challenges in the open‐data revolution
por: Salguero‐Gómez, Roberto, et al.
Publicado: (2021)

In vivo activation of transferred regulatory T cells specific for third‐party exogenous antigen controls GVH disease in mice
por: Martin, Gaëlle H., et al.
Publicado: (2013)

About gladiators and a sacred disease
por: Kattner, Aila Akosua
Publicado: (2022)

Dental pulp stem cells for treating neurodegenerative diseases
por: Shamir, Christopher, et al.
Publicado: (2015)

Door to the cell for COVID-19 opened, leading way to therapies
por: Huang, Zhiwei, et al.
Publicado: (2020)

Adenine base editing to mimic or correct disease mutations in rodents
por: Ren, Ruotong, et al.
Publicado: (2018)

Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer
por: Kurniawan, Henry, et al.
Publicado: (2020)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

Sex, Sleep, Steroids, and Lifestyle: Unraveling the Coronavirus Disease 2019 Conundrum
por: Sehgal, Vishal, et al.
Publicado: (2020)

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)

A new roadmap for the breeding of disease-resistant and high-yield crops
por: Wang, Yiming, et al.
Publicado: (2021)

Recent Biofilm Studies Open a New Door in Microbial Ecology
por: Kamagata, Yoichi
Publicado: (2020)

T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease
por: O'Connor, Richard A, et al.
Publicado: (2013)

C‐type lectin receptors of the Dectin‐1 cluster: Physiological roles and involvement in disease
por: Tone, Kazuya, et al.
Publicado: (2019)

Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment
por: Zhang, Chang-Ming, et al.
Publicado: (2016)

Modification of the susceptibility gene TaPsIPK1 - a win-win for wheat disease resistance and yield
por: Macho, Alberto, et al.
Publicado: (2022)

At Long Last: The Me(3)Si Group as a Masked Alcohol
por: Roy, Avijit, et al.
Publicado: (2021)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continues
por: Kayed, Rakez
Publicado: (2021)

‘Pyrococcus furiosus, 30 years on’
por: Kengen, Servé W. M.
Publicado: (2017)

Dendritic cell subsets in the intestinal lamina propria: Ontogeny and function
por: Persson, Emma K, et al.
Publicado: (2013)

Oxysterol-EBI2 signaling in immune regulation and viral infection
por: Daugvilaite, Viktorija, et al.
Publicado: (2014)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9pmekabhj7hfhf7fjqfq1nsjdg